ARCUS BIOSCIENCS

 RCUSのチャート


 RCUSの企業情報

symbol RCUS
会社名 Arcus Biosciences Inc (ARCUS BIOSCIENCS)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 Arcus Biosciences Inc. is a United States-based clinical-stage biotechnology company. The Company is focused on the discovery and development of cancer immunotherapy. Its pipeline includes AB928 AB680 AB122 and AB154. AB928 is a potent and selective dual antagonist of the adenosine receptors known as A2aR and A2bR.It is in the Phase-I clinical trial. AB680 is a potent and selective inhibitor of CD73 and is in the pre-clinical stage of development. AB122 is an anti-PD-1 antibody and is in the Phase-I dose-escalation trial. AB154 is a humanized anti-TIGIT antibody.  ア―カス・バイオサイエンシズは米国のバイオ医薬品企業。臨床段階で、がんに対し創造的で革新的な免疫治療の開発に従事する。同社は、科学的デ―タによって十分に特徴付けられた生物学的経路を標的とし、がんに対する免疫応答の調節の重要性に焦点を当てる。本社所在地はカリフォルニア州ヘイワ―ド。  Arcus Biosciences is an oncology-focused biopharmaceutical company leveraging its deep cross-disciplinary expertise to discover highly differentiated therapies and to develop a broad portfolio of novel combinations addressing significant unmet needs. Arcus currently has four molecules in clinical development: Etrumadenant (AB928), the first dual A2a/A2b adenosine receptor antagonist to enter the clinic, is being evaluated in multiple Phase 2 and 1b studies across different indications, including prostate, colorectal, non-small cell lung, pancreatic and triple-negative breast cancers. AB680, the first small-molecule CD73 inhibitor to enter the clinic, is in Phase 1/1b development for first-line treatment of metastatic pancreatic cancer in combination with zimberelimab and gemcitabine/nab-paclitaxel. Domvanalimab (AB154), an anti-TIGIT monoclonal antibody and new potential immuno-oncology backbone therapy, is in a three-arm randomized Phase 2 study for first-line treatment of PD-L1- 1.
本社所在地 3928 Point Eden Way Hayward CA 94545 USA
代表者氏名 Juan Carlos Jaen
代表者役職名 President Co-Founder
電話番号 +1 650-489-9000
設立年月日 42095
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 108人
url www.arcusbio.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -51.19500
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 557.12770
売上高 (百万ドル) 8.35300
企業価値(EV) (百万ドル) 300.58370
当期純利益 (百万ドル) -49.59400
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Arcus Biosciences Inc revenues increased from $1.4M to $8.4M. Net loss decreased 7% to $49.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Interest and other income net increase from $359K to $4.9M (income). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.27 to -$1.43.

 RCUSのテクニカル分析


 RCUSのニュース

   Arcus Biosciences Inc (RCUS) COO Jennifer Jarrett Sold $1.7 million of Shares  2021/09/23 01:15:02 GuruFocus
Related Stocks: RCUS ,
   Arcus Biosciences Announces New Employment Inducement Grants  2021/09/09 20:10:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Companys Board of Directors granted five new employees options to purchase a total of 44,200 shares of the Companys common stock at an exercise price per share of $34.31, which was the closing price on September 8, 2021. The stock options were granted pursuant to the Compan
   Arcus Biosciences to Participate at Upcoming Investor Conferences  2021/09/01 20:10:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the following upcoming September 2021 virtual investor conferences. Citis 16th Annual Virtual Biopharma Conference, Friday, September 10 at 1:25 pm ET 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27 at 4:40 pm ET A live audio webcast of the presentation will b
   PARK CIRCLE Co Buys Arcus Biosciences Inc, Triton International, Old Republic International ...  2021/08/23 18:38:23 GuruFocus
Related Stocks: TRTN , MO , MRK , LITE , RCUS , ORI , SUN , BMY , TTE , TSLX , T , GE ,
   Arcus Biosciences Inc (RCUS): Price Now Near $27.89; Daily Chart Shows An Uptrend on 50 Day Basis  2021/08/18 15:18:41 ETF Daily News
It''s been a feast for bears operating on an hourly timeframe, as rcus has now gone down 4 of the past 5 hours. The post Arcus Biosciences Inc (RCUS): Price Now Near $27.89; Daily Chart Shows An Uptrend on 50 Day Basis appeared first on ETF Daily News .
   Arcus Biosciences Inc (RCUS) COO Jennifer Jarrett Sold $1.7 million of Shares  2021/09/23 01:15:02 GuruFocus
Related Stocks: RCUS ,
   Arcus Biosciences Announces New Employment Inducement Grants  2021/09/09 20:10:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Companys Board of Directors granted five new employees options to purchase a total of 44,200 shares of the Companys common stock at an exercise price per share of $34.31, which was the closing price on September 8, 2021. The stock options were granted pursuant to the Compan
   Arcus Biosciences to Participate at Upcoming Investor Conferences  2021/09/01 20:10:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the following upcoming September 2021 virtual investor conferences. Citis 16th Annual Virtual Biopharma Conference, Friday, September 10 at 1:25 pm ET 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27 at 4:40 pm ET A live audio webcast of the presentation will b
   PARK CIRCLE Co Buys Arcus Biosciences Inc, Triton International, Old Republic International ...  2021/08/23 18:38:23 GuruFocus
Related Stocks: TRTN , MO , MRK , LITE , RCUS , ORI , SUN , BMY , TTE , TSLX , T , GE ,
   Arcus Biosciences Inc (RCUS): Price Now Near $27.89; Daily Chart Shows An Uptrend on 50 Day Basis  2021/08/18 15:18:41 ETF Daily News
It''s been a feast for bears operating on an hourly timeframe, as rcus has now gone down 4 of the past 5 hours. The post Arcus Biosciences Inc (RCUS): Price Now Near $27.89; Daily Chart Shows An Uptrend on 50 Day Basis appeared first on ETF Daily News .
   Arcus Biosciences Announces New Employment Inducement Grants  2021/09/09 20:10:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Companys Board of Directors granted five new employees options to purchase a total of 44,200 shares of the Companys common stock at an exercise price per share of $34.31, which was the closing price on September 8, 2021. The stock options were granted pursuant to the Compan
   Arcus Biosciences to Participate at Upcoming Investor Conferences  2021/09/01 20:10:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the following upcoming September 2021 virtual investor conferences. Citis 16th Annual Virtual Biopharma Conference, Friday, September 10 at 1:25 pm ET 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27 at 4:40 pm ET A live audio webcast of the presentation will b
   PARK CIRCLE Co Buys Arcus Biosciences Inc, Triton International, Old Republic International ...  2021/08/23 18:38:23 GuruFocus
Related Stocks: TRTN , MO , MRK , LITE , RCUS , ORI , SUN , BMY , TTE , TSLX , T , GE ,
   Arcus Biosciences Inc (RCUS): Price Now Near $27.89; Daily Chart Shows An Uptrend on 50 Day Basis  2021/08/18 15:18:41 ETF Daily News
It''s been a feast for bears operating on an hourly timeframe, as rcus has now gone down 4 of the past 5 hours. The post Arcus Biosciences Inc (RCUS): Price Now Near $27.89; Daily Chart Shows An Uptrend on 50 Day Basis appeared first on ETF Daily News .
   Arcus Biosciences Inc Shares Close the Day 10.6% Lower - Daily Wrap  2021/08/06 22:53:50 Kwhen Finance
Arcus Biosciences Inc (RCUS) shares closed today 10.6% lower than it did at the end of yesterday. The stock is currently up 17.4% year-to-date, up 43.3% over the past 12 months, and up 79.3% over the past five years. Today, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.2%. Trading Activity Shares traded as high as $33.27 and as low as $29.18 this week.Shares closed 35.6% below its 52-week high and 63.3% above its 52-week low.Trading volume this week was 4.7% higher than the 10-day average and 30.6% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -155.8% The company's stock price performance over the past 12 months beats the peer average by -315.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (医薬品 米国株 ARCUS BIOSCIENCS RCUS )

 twitter  (公式ツイッターやCEOツイッターなど)